Evidence map›Paper›PMID 32176331›Full record

ArticleCancer2020

An evolutionary framework for treating pediatric sarcomas.

Damon R Reed, Jonathan Metts, Mariyah Pressley, Brooke L Fridley, Masanori Hayashi, Michael S Isakoff, David M Loeb, Rikesh Makanji, Ryan D Roberts, Matteo Trucco and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06384404 (Functional Outcomes in Patients Who Undergo Upfront Surgical Resection for High-Grade Osteosarcoma of the Extremity), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06384404 recruitingnot on this mapstarted 2024, after this paper: background citation

Functional Outcomes in Patients Who Undergo Upfront Surgical Resection for High-Grade Osteosarcoma of the Extremity: A Pilot Study

TypeobservationalSponsorMontefiore Medical CenterRan2024 to 2028Enrolled10ConditionsOsteosarcomaArmsQuestionnaire
3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Treatment of evolving cancers will require dynamic decision support.Annals of oncology : official journal of the European Society for Medical Oncology · 2023
    Review
  18. Article
  19. Modeling cancer's ecological and evolutionary dynamics.Medical oncology (Northwood, London, England) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Damon R ReedDepartment of Interdisciplinary Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.ORCID 0000-0002-8238-2465
Jonathan MettsCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida.
Mariyah PressleyCancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Brooke L FridleyCancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Masanori HayashiDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Michael S IsakoffCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut.ORCID 0000-0003-4790-9919
David M LoebDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, New York.
Rikesh MakanjiDiagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Ryan D RobertsDepartment of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio.ORCID 0000-0001-5028-744X
Matteo TruccoDepatment of Pediatrics, University of Miami, Miami, Florida.
Lars M WagnerDepartment of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Mark G AlexandrowCancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.ORCID 0000-0003-4661-0368
Robert A GatenbyCancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Joel S BrownCancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Elucidating and exploiting the mechanisms by which IL-6 and IL-8 facilitate osteosarcoma metastasisK08CA201638 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI ROBERTS, RYAN D. · 2016 to 2020
$815k
NCI NIH HHS K08 CA201638NCI NIH HHS P30 CA013330NCI NIH HHS U54 CA143970
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological EvolutionBone NeoplasmsChildClinical Trials as TopicHumansModels, TheoreticalOsteosarcomaRhabdomyosarcomaSarcomaSarcoma, EwingSelection, Geneticadaptive therapyclinical trialevolutionEwing sarcomaextinction therapyfirst strikeosteosarcomaresistancerhabdomyosarcomasecond strike

Identifiers

PMID32176331
PMCPMC7318114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.